CARB-X
US and UK partnership to fund the fight against superbugs
March 31, 2017Medical Communications, Research and Development CARB-X, Wellcome Trust
The cross-Atlantic partnership CARB-X, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, has announced that it would be funding 11 biotech companies …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
